D049268
Sponsors
Murakami Takaaki, Okazawa Hidehiko, Takado Yuhei, Endo Hironobu, Narita Yoshitaka
Conditions
Dementia with Lewy bodies, Parkinson's disease, and multiple system atrophyDiffuse gastric cance (poorly differentiated adenocarcinoma)
gastric cancer, poorly differentiated, diffuse, scirrhous, signet-ring cellRecurrent Malignant brain tumors, including gliomas and brain metastases
recurrent, brain tumor, glioma, brain metastasisType 1 diabetes mellitus
Type 1 diabetes mellitusgynecologic malignancy, gastric cancer, head and neck cancer, pancreas cancer and breast cancer
malignant solid tumorsmetastatic bone tumor
PET, bone meta.mild cognitive impairment, Alzheimers disease, progressive supranuclear palsy, and so on.
Phase 2
Investigation of the pathogenesis of type 1 and insulin-dependent diabetes mellitus using a noninvasive pancreatic beta cell imaging technique
Active, not recruitingJPRN-jRCT1051220023
Start: 2022-05-17Target: 40Updated: 2026-06-29
Analyzing the diagnostic potential of 18F-Fluciclovine PET for suspected recurrence of malignant brain tumors
RecruitingJPRN-jRCTs031250210
Start: 2025-07-04Target: 20Updated: 2026-06-29
Exploratory clinical trial to evaluate the efficacy and safety of FAPI-PET for diffuse gastric cancer
RecruitingJPRN-jRCTs031250386
Start: 2025-11-18Target: 20Updated: 2026-06-29
FAPET study
RecruitingJPRN-jRCTs051260002
Start: 2026-04-07Target: 120Updated: 2026-06-29
Unknown Phase
In vivo comparison within the enantiomers of [18F]PM-PBB3
Active, not recruitingJPRN-jRCTs031190114
Start: 2019-12-04Target: 35Updated: 2026-06-29
Investigation for efficacy and safety of [18F] SPAL-T-06
Active, not recruitingJPRN-jRCTs031210180
Start: 2021-07-29Target: 30Updated: 2026-06-29
Investigation for efficacy and safety of [18F] C05-05
Active, not recruitingJPRN-jRCTs031220123
Start: 2022-06-22Target: 116Updated: 2026-06-29
[F-18]NaF-PET for bone imaging
Active, not recruitingJPRN-jRCT2052230066
Start: 2023-07-31Target: 23Updated: 2026-06-29